Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Stanford MoTrPAC Bioinformatics Center
Environmental Adaptation and Membrane Physiology of an Oral Pathogen
Communities United for Substance Abuse Prevention
Immunotoxin Therapy for Prostatic Carcinomas
Calcium and Signal Transduction
Recently added grants:
Examining the Consequences of Reductions in Opioid Prescribing on Patients, Clinical Care, and Community Health
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance
Lipidome Remodeling During Development of T1D
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095000-002
Application #
6688604
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant